Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05466682
Other study ID # 17-00525-2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 9, 2022
Est. completion date June 19, 2023

Study information

Verified date January 2024
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this research is to assess the utility of smartphone-based progressive muscle relaxation (PMR) for the treatment of migraine and sleep. While there are many commercially available electronic diary and mind-body intervention apps for headache, there is little data showing their efficacy. RELAXaHEAD app incorporates the electronic PMR that was successfully used in an earlier epilepsy study and beta tested with headache specialist and migraine patient input. It also is an electric headache diary. The app has been studied and findings have been reported in multiple peer reviewed publications. Also, the app has been updated based on prior feedback from the studies. Now, this 2-arm randomized controlled study will evaluate the feasibility and acceptability of RELAXaHEAD for use with patients with migraine and comorbid insomnia. . One arm will be the RELAX group (the RELAXaHEAD app) and the other arm will be a monitored usual care (MUC) group (this group receives standard of care and uses the electronic daily symptom reporting diary). The goals are to assess the feasibility and adherence of the RELAX intervention in persons with migraine and insomnia (Aim 1) and to gather exploratory data on the effects of the RELAX intervention on headache and sleep related outcome measures (Aim 2).


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date June 19, 2023
Est. primary completion date December 19, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Age 18-80 years (age 18-65 in urgent care); - Meets migraine criteria based on the International Classification of Headache Disorders (ICHD) criteria; - Migraine Disability Assessment (MIDAS) score >5. 4+ headache days a month OR; meets chronic post- traumatic headache (PTH) criteria based on International Classification of Headache Disorders (ICHD) criteria, is 3-12 months post-injury, and there are 4+ headache days a month. - Scoring > or = 15 on the ISI. Exclusion Criteria: - Patients who have had Cognitive Behavioral Therapy, Biofeedback, or other Relaxation Therapy in the past year; - Cognitive deficit or other physical problem with the potential to interfere with behavioral therapy; - Alcohol or other substance abuse as determined by self-report or prior documentation in the medical record; - Opioid or barbiturate use 10+ days a month; - Unable or unwilling to follow a treatment program that relies on written and audio file materials; - Not having a smartphone.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Smartphone-Based Progressive Muscle Relaxation Therapy (PMR)
Relaxation technique delivered via RELAXaHEAD app.
Monitored Usual Care (MUC)
Standard of care plus daily symptom reporting using the RELAXaHEAD app electronic diary.

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (3)

Lead Sponsor Collaborator
NYU Langone Health Center for Advancing Point of Care Technologies, National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients Enrolled in the Study Measure of feasibility. Baseline
Primary Daily Diary Satisfaction Scores 5-item self-assessment measuring satisfaction with the daily dairy function of the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-20; higher scores indicate higher levels of satisfaction.
Baseline
Primary Daily Diary Satisfaction Scores 5-item self-assessment measuring satisfaction with the daily dairy function of the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-20; higher scores indicate higher levels of satisfaction.
Week 1
Primary Daily Diary Satisfaction Scores 5-item self-assessment measuring satisfaction with the daily dairy function of the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-20; higher scores indicate higher levels of satisfaction.
Month 1
Primary Daily Diary Satisfaction Scores 5-item self-assessment measuring satisfaction with the daily dairy function of the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-20; higher scores indicate higher levels of satisfaction.
Month 2
Primary Daily Diary Satisfaction Scores 5-item self-assessment measuring satisfaction with the daily dairy function of the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-20; higher scores indicate higher levels of satisfaction.
Month 3
Primary Progressive Muscle Relaxation Therapy (PMR) Satisfaction Scores Among RELAX Arm Participants 4-item self-assessment measuring satisfaction with PMR administered via the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-16; higher scores indicate higher levels of satisfaction
Baseline
Primary Progressive Muscle Relaxation Therapy (PMR) Satisfaction Scores Among RELAX Arm Participants 4-item self-assessment measuring satisfaction with PMR administered via the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-16; higher scores indicate higher levels of satisfaction
Week 1
Primary Progressive Muscle Relaxation Therapy (PMR) Satisfaction Scores Among RELAX Arm Participants 4-item self-assessment measuring satisfaction with PMR administered via the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-16; higher scores indicate higher levels of satisfaction
Month 1
Primary Progressive Muscle Relaxation Therapy (PMR) Satisfaction Scores Among RELAX Arm Participants 4-item self-assessment measuring satisfaction with PMR administered via the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-16; higher scores indicate higher levels of satisfaction
Month 2
Primary Progressive Muscle Relaxation Therapy (PMR) Satisfaction Scores Among RELAX Arm Participants 4-item self-assessment measuring satisfaction with PMR administered via the RELAXaHEAD app. Items are ranked on a 5-point Likert scale, where: 0 = Strongly Disagree; 1 = Disagree; 2 = Neither Agree nor Disagree; 3 = Agree; and 4 = Strongly Agree.
The total score is the sum of responses. Scores range from 0-16; higher scores indicate higher levels of satisfaction
Month 3
Primary Number of Days RELAX Arm Participants Performed Progressive Muscle Relaxation Therapy (PMR) at Least 5 Minutes/Day Calculated using the backend analytics in the RELAXaHEAD app. Measure of feasibility. Up to Month 3
Primary Number of Days Participants Used Diary Calculated using the backend analytics in the RELAXaHEAD app. Measure of feasibility. Up to Month 3
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4